Relief therapeutics « Terug naar discussie overzicht

Relief Therapeutics januari 2023

34 Posts, Pagina: « 1 2 | Laatste
laatsteloodje
0
De PKU GOLIKE BARs® zijn nu ook in Europa verkrijgbaar.
relieftherapeutics.com/newsblog-detai...

De nieuwe PKU GOLIKE BAR's zijn er in tropische en rode fruitsmaken en bevatten natuurlijke ingrediënten en echt fruit.
Smakelijk
laatsteloodje
0
ACER

ACER-801 (Osanetant) werd veilig en goed verdragen, maar er is geen statistisch significante afname van frequentie of ernst van opvliegers bij postmenopauzale vrouwen.
Daarom wordt de studie tijdelijk gestopt tot alle data daar zijn..
www.acertx.com/2023/03/17/acer-therap...
laatsteloodje
0
APR

PKU Golike : Relief presenteert op de Society for Inherited Metabolic Disorders 44th Annual Meeting : betere fysiologische absorptie van een aminozuurpreparaat met verlengde afgifte.
Preklinisch bewijs voor een beter aminozuurgebruik.
relieftherapeutics.com/newsblog-detai...
DeZwarteRidder
0
laatsteloodje
0
laatsteloodje
0
DeZwarteRidder
0
quote:

laatsteloodje schreef op 3 mei 2023 09:36:

Handelsdatum nieuwe aandelen 5 mei.
relieftherapeutics.com/newsblog-detai...
Ik voorspel een koersstijging van ca 400% en daarna een flinke koersdaling.
DeZwarteRidder
0
Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
03.05.2023 / 07:00 CET/CEST

Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares

GENEVA (May 3, 2023) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief Therapeutics), a biopharmaceutical company committed to delivering innovative treatment options with the potential for transformative outcomes to benefit those suffering from select specialty and rare diseases, today announced the implementation timeline for the reverse split of its ordinary shares, which was approved by shareholders at the Extraordinary General Meeting held on April 28, 2023.

May 4, 2023: Last trading day of old shares on SIX Swiss Exchange
May 5, 2023: First trading day of new shares on SIX Swiss Exchange

As previously communicated, shareholdings will be rounded down to the next lower whole number of new merged shares by applying the 400 to 1 exchange ratio. The resulting fractions will be compensated in cash at a fixed price corresponding to the three-day volume-weighted average price of the Relief Therapeutics share on the SIX Swiss Exchange prior to the reverse split.

Additional information on the reverse split is provided in a Q&A list available here.

ABOUT RELIEF THERAPEUTICS

Relief Therapeutics is a commercial-stage biopharmaceutical company committed to advancing treatment paradigms and delivering improvements in efficacy, safety and convenience to benefit the lives of patients living with select specialty and rare diseases. Relief Therapeutics’ portfolio offers a balanced mix of marketed, revenue-generating products, our proprietary, globally patented Physiomimic™ and TEHCLO™ drug delivery platform technologies and a highly targeted clinical development pipeline consisting of risk-mitigated assets focused in three core therapeutic areas: rare metabolic disorders, rare skin diseases and rare respiratory diseases. In addition, Relief Therapeutics is commercializing several legacy products via licensing and distribution partners. Our mission to provide therapeutic relief to those suffering from rare diseases is being advanced by an international team of well-established, experienced biopharma industry leaders with extensive research, development and rare disease expertise. Relief Therapeutics is headquartered in Geneva, with additional offices in Balerna, Switzerland, Offenbach am Main, Germany and Rome. Relief Therapeutics is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFTF and RLFTY. For more information, please visit our website www.relieftherapeutics.com or follow Relief Therapeutics on LinkedIn and Twitter
DeZwarteRidder
0
quote:

DeZwarteRidder schreef op 3 mei 2023 09:39:

[...]Ik voorspel een koersstijging van ca 400% en daarna een flinke koersdaling.
LOL

Aandeelhouders van dit bedrijfje zijn niet erg slim.....!!!
DeZwarteRidder
0
quote:

DeZwarteRidder schreef op 3 mei 2023 09:39:

[...]Ik voorspel een koersstijging van ca 400% en daarna een flinke koersdaling.
Omgerekend is Relief nu nog 1,3 cent waard.
34 Posts, Pagina: « 1 2 | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 7 okt 2024 17:31
Koers 2,950
Verschil +0,200 (+7,27%)
Hoog 2,990
Laag 2,810
Volume 119.569
Volume gemiddeld 59.074
Volume gisteren 209.880

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront